Higher NK cell numbers within the ascites of ovarian cancer patients have been correlated to increased survival and better outcomes [33]; therefore, we hypothesized that combining an HER2-targeted ADCC with an NK specific proliferation signal would greatly enhance endogenous NK cell activity in the ovarian cancer setting. The gene discussed is ERBB2; the disease is ovarian carcinoma.